chr18-57650359-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001374385.1(ATP8B1):​c.3531+8G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,611,714 control chromosomes in the GnomAD database, including 20,984 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1453 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19531 hom. )

Consequence

ATP8B1
NM_001374385.1 splice_region, intron

Scores

2
Splicing: ADA: 0.0001719
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.578

Publications

10 publications found
Variant links:
Genes affected
ATP8B1 (HGNC:3706): (ATPase phospholipid transporting 8B1) This gene encodes a member of the P-type cation transport ATPase family, which belongs to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to another. Mutations in this gene may result in progressive familial intrahepatic cholestasis type 1 and in benign recurrent intrahepatic cholestasis. [provided by RefSeq, Jul 2008]
ATP8B1-AS1 (HGNC:56042): (ATP8B1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 18-57650359-C-A is Benign according to our data. Variant chr18-57650359-C-A is described in ClinVar as [Benign]. Clinvar id is 259822.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP8B1NM_001374385.1 linkc.3531+8G>T splice_region_variant, intron_variant Intron 27 of 27 ENST00000648908.2 NP_001361314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP8B1ENST00000648908.2 linkc.3531+8G>T splice_region_variant, intron_variant Intron 27 of 27 NM_001374385.1 ENSP00000497896.1 O43520

Frequencies

GnomAD3 genomes
AF:
0.122
AC:
18489
AN:
152064
Hom.:
1453
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0314
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.154
Gnomad ASJ
AF:
0.193
Gnomad EAS
AF:
0.00845
Gnomad SAS
AF:
0.126
Gnomad FIN
AF:
0.144
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.171
Gnomad OTH
AF:
0.139
GnomAD2 exomes
AF:
0.140
AC:
35128
AN:
251462
AF XY:
0.144
show subpopulations
Gnomad AFR exome
AF:
0.0295
Gnomad AMR exome
AF:
0.141
Gnomad ASJ exome
AF:
0.203
Gnomad EAS exome
AF:
0.00549
Gnomad FIN exome
AF:
0.135
Gnomad NFE exome
AF:
0.172
Gnomad OTH exome
AF:
0.152
GnomAD4 exome
AF:
0.159
AC:
232074
AN:
1459532
Hom.:
19531
Cov.:
31
AF XY:
0.158
AC XY:
115035
AN XY:
726112
show subpopulations
African (AFR)
AF:
0.0256
AC:
855
AN:
33416
American (AMR)
AF:
0.144
AC:
6442
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.197
AC:
5142
AN:
26078
East Asian (EAS)
AF:
0.00546
AC:
216
AN:
39578
South Asian (SAS)
AF:
0.136
AC:
11702
AN:
86188
European-Finnish (FIN)
AF:
0.139
AC:
7382
AN:
53150
Middle Eastern (MID)
AF:
0.139
AC:
800
AN:
5752
European-Non Finnish (NFE)
AF:
0.172
AC:
190854
AN:
1110490
Other (OTH)
AF:
0.144
AC:
8681
AN:
60232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
10236
20472
30707
40943
51179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6616
13232
19848
26464
33080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.121
AC:
18484
AN:
152182
Hom.:
1453
Cov.:
32
AF XY:
0.120
AC XY:
8891
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0313
AC:
1301
AN:
41530
American (AMR)
AF:
0.154
AC:
2344
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.193
AC:
668
AN:
3470
East Asian (EAS)
AF:
0.00847
AC:
44
AN:
5194
South Asian (SAS)
AF:
0.127
AC:
610
AN:
4822
European-Finnish (FIN)
AF:
0.144
AC:
1522
AN:
10582
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.171
AC:
11615
AN:
68002
Other (OTH)
AF:
0.136
AC:
287
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
800
1601
2401
3202
4002
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
1232
Bravo
AF:
0.117
Asia WGS
AF:
0.0700
AC:
245
AN:
3478
EpiCase
AF:
0.166
EpiControl
AF:
0.169

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Progressive familial intrahepatic cholestasis type 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cholestasis, intrahepatic, of pregnancy, 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.4
DANN
Benign
0.37
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00017
dbscSNV1_RF
Benign
0.016
SpliceAI score (max)
0.26
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.26
Position offset: -34

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34027711; hg19: chr18-55317591; API